The White House says people of color are being hit harder by diseases simply because medicines and treatments haven't effectively been tested on diverse populations.
The latest omnibus bill includes legislation that will codify FDA guidelines for diversity in clinical trials into law. Learn more about what this means for sponsors.
M&B Sciences Inc Acquires Clara Health and Announces Goal to Become a Leader in Patient Recruitment and Retention in Clinical Trials March 09, 2022 09:29 AM Eastern Standard Time SAN DIEGO, Calif.–(BUSINESS WIRE)–M&B Sciences Inc, a fast-growing African-American owned, technology-driven clinical research organization, announces the acquisition of Clara Health, a company dedicated to using technology...